I am surprised this stock is still very much under the radar. Some highlights from the investor presentation on 20th Feb 14 (date of the ASX listing) include:
"Simavita has developed and commercialised the world’s first and only instrumented incontinence assessment medical device-SIM™." "Aging global population - an investment mega-trend" "Commercialized product - FDA clearance in place" "3 granted patents" "Global coverage pending"
These are only a few highlights. The entire document is a good read.
The company listed on the TXSV (Canada, code SV) on 6th Dec 13. I know incontinence is a boring subject but it's a very real, albeit secretive, issue for patients and their carers.
This company appears to have a solution which is already being sold in Australia with US distribution starting in Q1 2014 and is advancing global distribution discussions in Canada and the EU.
In summary they have a ready-to-market, in demand product already being distributed and with seemingly no competitors at this stage. It's already had a run and pulled back a bit since listing but at .88c it seem very undervalued. It's very illiquid but I think that will change as global sales start to pickup. I have yet to take up a position and am curious as to what others think about this stock. Sue
SVA Price at posting:
88.0¢ Sentiment: LT Buy Disclosure: Not Held
